Pfizer (PFE) Goodwill & Intangibles (2016 - 2025)
Pfizer (PFE) has disclosed Goodwill & Intangibles for 17 consecutive years, with $125.0 billion as the latest value for Q4 2025.
- Quarterly Goodwill & Intangibles rose 0.85% to $125.0 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $125.0 billion through Dec 2025, up 0.85% year-over-year, with the annual reading at $125.0 billion for FY2025, 0.85% up from the prior year.
- Goodwill & Intangibles for Q4 2025 was $125.0 billion at Pfizer, up from $120.4 billion in the prior quarter.
- The five-year high for Goodwill & Intangibles was $132.7 billion in Q4 2023, with the low at $74.4 billion in Q4 2021.
- Average Goodwill & Intangibles over 5 years is $102.6 billion, with a median of $94.1 billion recorded in 2022.
- The sharpest move saw Goodwill & Intangibles dropped 16.55% in 2021, then soared 41.34% in 2024.
- Over 5 years, Goodwill & Intangibles stood at $74.4 billion in 2021, then rose by 27.42% to $94.7 billion in 2022, then soared by 40.04% to $132.7 billion in 2023, then dropped by 6.59% to $123.9 billion in 2024, then grew by 0.85% to $125.0 billion in 2025.
- According to Business Quant data, Goodwill & Intangibles over the past three periods came in at $125.0 billion, $120.4 billion, and $121.7 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.